2nd Annual Discovery Chemistry & Drug Design Congress

Day 1: Discovery Chemistry: Latest Case Studies
Fragment based and structure based drug discovery
Analysing structure-activity relationships
Chemical genetic approaches
Hybrid approaches: combining biology and chemistry expertise
Advances in computational chemistry & flow chemistry
The role of natural products in discovery chemistry
Key learnings from ligand binding studies

Day 2: Drug Design: Novel Approaches
Lead optimisation: considering solubility, drugability and potency
Achieving selectivity and specificity
DMPK considerations in lead optimisation
Early de-risking through drug design
Water molecules: assessing the impact on drug discovery and design
Building increased molecular complexity into drug design
Computer aided design for biologics

 Please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk for the full agenda.